Medical Marijuana Quality Assessment
IN PHOTO: Director of Quality Assurance Thomas Shipley prunes dry marijuana buds before they are processed for shipping at Tweed Marijuana Inc in Smith's Falls, Ontario, April 22, 2014. By unlocking the once-obscure medical marijuana market, Canada has created a fast-growing, profitable and federally regulated industry with a distinct appeal to the more daring global investor. About a dozen producers of the drug will find themselves in the spotlight this year as they consider going public or prepare to so through share sales or reverse takeovers to capitalize on recent regulatory changes, investment bankers said. Tweed Marijuana Inc, which converted an old chocolate factory into a marijuana farm, led the pack by becoming the first publicly held Canadian company in the sector. Picture taken April 22, 2014. Reuters/Blair Gable

In an attempt to help find a breakthrough treatment for children with epilepsy and other terminally-ill patients, Victoria and Queensland states have decided to join New South Wales (NSW) for medical marijuana trials. The groundbreaking treatment using cannabis oil will potentially help cure chemotherapy-related nausea as well.

The decision came after NSW announced that it will conduct the marijuana clinical testing back in December 2014. The representative of the two Australian states who joined NSW, said that they have decided to conduct similar trials. The announcement was made after the Council of Australian Governments (Coag) meeting on 17th April, 2015.

“Prior to the Coag meeting I was fortunate enough to have a conversation with the NSW premier Mike Baird and Victorian premier Daniel Andrews. I would like to place on the record my thanks to premier Mike Baird for his leadership in relation to this issue. I could not let Queensland sit back and watch. I could not let Queensland just be an observer at the trials,” said the Queensland premier Annastacia Palaszczuk, reported The Guardian.

On the other hand, Jill Hennessy, the Victorian health minister confirmed that attempts are being made to collaborate the Victorian government and the NSW Health officials. She further added on to say that the step would help the Victorians take part in the clinical trial.

"Many Victorians with terminal illnesses or life-threatening conditions want to use medical cannabis to relieve their pain and treat their conditions, but currently cannot legally do so. By supporting and participating in these important trials with NSW, we can help the evidence building around medicinal cannabis," said Hennessy, reported The Sydney Morning Herald.

The NSW trials are estimated to cost $9 million and will span across three phases—trial for children with epilepsy who have not responded to any traditional medicine, trials for adults affected with terminal illness followed by the trials for individuals with chemotherapy induced nausea.

To report a problem or to leave a feedback on the article, send an e-mail to emailtoguneet@gmail.com.

RELATED STORIES